Delivery Order SPE2DB20D2002-SPE2DB25FL39V
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,977.03 firm fixed-price contract is for the delivery of 4,567,875,611 units of the prescription medication Ondansetron HCL 4 mg tablet. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,730.72 firm-fixed-price contract is for the delivery of 4,568,076 units of the medication Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,158.00, is for the delivery of 4,568,013,655 units of Ondansetron HCL 4 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through April 24, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, with a total ceiling value of $3,608.26 and a period of performance ending on April 18, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,377.96, is for the delivery of 4,567,553,701 units of Ondansetron ODT 4 mg tablets. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,116.51 contract is for the supply of 4,559,438,684 units of Ondansetron HCL 4 mg tablets. The contract has a period of performance through December 22, 2022 and was awarded on December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,116,842 units of the drug Ondansetron ODT 4 mg tablets. The award has a ceiling value of $5,097.98 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of 4,560,665 units of Ondansetron HCL 4 mg tablets. The contract has a firm fixed price of $5,962.99 and a period of performance through April 21, 2023. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,667.44, is for the delivery of 500 units of the pharmaceutical product Ondansetron HCL 4 mg Tablet. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,091.36, is for the delivery of 4,566,561,598 units of 8 mg Ondansetron HCL tablets. The award has a firm fixed price and an ultimate completion date of November 29, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...